MHRA
-

MHRA Issues Urgent Safety Warnings for Botulinum Toxin Products Following Botulism Cases
The MHRA has mandated updated safety warnings for all botulinum toxin type A products following rare reports of iatrogenic botulism spreading beyond injection sites.
